NO982988L - Middel for profylakse og behandling av diabetiske komplikasjoner - Google Patents
Middel for profylakse og behandling av diabetiske komplikasjonerInfo
- Publication number
- NO982988L NO982988L NO982988A NO982988A NO982988L NO 982988 L NO982988 L NO 982988L NO 982988 A NO982988 A NO 982988A NO 982988 A NO982988 A NO 982988A NO 982988 L NO982988 L NO 982988L
- Authority
- NO
- Norway
- Prior art keywords
- prophylaxis
- treatment
- diabetic complications
- present
- remedy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34016195 | 1995-12-27 | ||
PCT/JP1996/003776 WO1997024333A1 (fr) | 1995-12-27 | 1996-12-24 | Composes de prevention/traitement s'appliquant aux complications de diabetes |
Publications (3)
Publication Number | Publication Date |
---|---|
NO982988D0 NO982988D0 (no) | 1998-06-26 |
NO982988L true NO982988L (no) | 1998-08-26 |
NO316494B1 NO316494B1 (no) | 2004-02-02 |
Family
ID=18334321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO982988A NO316494B1 (no) | 1995-12-27 | 1998-06-26 | Anvendelse av forbindelse for fremstilling av medikament for profylakse og behandling av diabetiske komplikasjoner |
Country Status (23)
Country | Link |
---|---|
US (8) | US6060496A (no) |
EP (2) | EP0881218B1 (no) |
JP (1) | JP3448869B2 (no) |
KR (2) | KR100443891B1 (no) |
CN (2) | CN1159009C (no) |
AT (1) | ATE252563T1 (no) |
AU (1) | AU716332B2 (no) |
BG (1) | BG63803B1 (no) |
BR (1) | BR9612316A (no) |
CA (1) | CA2241856C (no) |
CZ (1) | CZ294485B6 (no) |
DE (1) | DE69630465T2 (no) |
EE (1) | EE03524B1 (no) |
ES (1) | ES2210399T3 (no) |
HK (1) | HK1015777A1 (no) |
HU (1) | HUP0000422A3 (no) |
IL (1) | IL125104A (no) |
IS (1) | IS4784A (no) |
MX (1) | MX9805317A (no) |
NO (1) | NO316494B1 (no) |
NZ (1) | NZ324454A (no) |
RU (1) | RU2173148C2 (no) |
WO (1) | WO1997024333A1 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EE03524B1 (et) * | 1995-12-27 | 2001-10-15 | Yoshitomi Pharmaceutical Industries, Ltd. | Vahend diabeedi komplikatsioonide profülaktikaks ja raviks |
DE60034448D1 (de) * | 1999-05-25 | 2007-05-31 | Mitsubishi Pharma Corp | PROMOTOREN FüR DIE EXPRESSION DES MYELIN ASSOZIIERTEN GLYCOPROTEINS (MAG) |
US6482844B1 (en) * | 2000-04-07 | 2002-11-19 | Neurogen Corporation | 1-benzylimidazole derivatives |
EP1352569A1 (en) * | 2000-11-24 | 2003-10-15 | Toyo Shinyaku Co., Ltd. | Foods containing young wheat leaf powder |
DE10229180A1 (de) | 2002-06-28 | 2004-01-29 | Aventis Pharma Deutschland Gmbh | Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen |
WO2004021014A2 (en) * | 2002-08-29 | 2004-03-11 | University Of Florida Research Foundation, Inc. | Cox-2 mediated altered prostaglandin balance in diabetes complications |
GB0314945D0 (en) * | 2003-06-26 | 2003-07-30 | Black & Decker Inc | Vacuum cleaner |
EP2234608A2 (en) | 2007-12-11 | 2010-10-06 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
RU2741715C1 (ru) * | 2020-03-20 | 2021-01-28 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный медицинский университет имени академика Е.А. Вагнера" Министерства здравоохранения Российской Федерации | Способ прогнозирования формирования микрососудистых осложнений сахарного диабета 2 типа |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK531479A (da) * | 1979-01-19 | 1980-07-20 | Pfizer | Fremgangsmaade til fremstilling af imidazolderivater og salte deraf |
JPS61277670A (ja) * | 1985-06-03 | 1986-12-08 | Yoshitomi Pharmaceut Ind Ltd | イミダゾ−ル誘導体 |
US4661603A (en) * | 1982-03-03 | 1987-04-28 | Yoshitomi Pharmaceutical Industries, Ltd. | Imidazole derivatives |
JPS6147477A (ja) * | 1984-08-14 | 1986-03-07 | Kowa Co | 新規1,4−ジヒドロピリジン−3,5−ジカルボン酸エステル誘導体 |
JPS63119425A (ja) * | 1986-11-07 | 1988-05-24 | Yoshitomi Pharmaceut Ind Ltd | 免疫機能改善薬 |
PH24144A (en) * | 1987-06-03 | 1990-03-22 | Erba Carlo Spa | A method of treating nephropathies using n-imidazolyl derivatives of bicyclic compounds |
JP2814513B2 (ja) * | 1988-02-03 | 1998-10-22 | 吉富製薬株式会社 | 溶出性の改良された製剤組成物 |
WO1989006959A1 (en) * | 1988-02-03 | 1989-08-10 | Yoshitomi Pharmaceutical Industries, Ltd. | Pharmaceutical composition having improved releasability |
JPH037281A (ja) * | 1989-03-31 | 1991-01-14 | Kyoto Yakuhin Kogyo Kk | 新規イミダゾール誘導体およびその医薬用途 |
CA2030557A1 (en) | 1989-03-31 | 1990-10-01 | Hiroshi Matsui | Imidazole derivatives, methods for their production and pharmaceutical use thereof |
US5401851A (en) * | 1992-06-03 | 1995-03-28 | Eli Lilly And Company | Angiotensin II antagonists |
EE03524B1 (et) * | 1995-12-27 | 2001-10-15 | Yoshitomi Pharmaceutical Industries, Ltd. | Vahend diabeedi komplikatsioonide profülaktikaks ja raviks |
-
1996
- 1996-12-24 EE EE9800208A patent/EE03524B1/xx not_active IP Right Cessation
- 1996-12-24 BR BR9612316A patent/BR9612316A/pt not_active Application Discontinuation
- 1996-12-24 ES ES96942640T patent/ES2210399T3/es not_active Expired - Lifetime
- 1996-12-24 AT AT96942640T patent/ATE252563T1/de not_active IP Right Cessation
- 1996-12-24 CA CA002241856A patent/CA2241856C/en not_active Expired - Fee Related
- 1996-12-24 EP EP96942640A patent/EP0881218B1/en not_active Expired - Lifetime
- 1996-12-24 WO PCT/JP1996/003776 patent/WO1997024333A1/ja active IP Right Grant
- 1996-12-24 KR KR10-1998-0702751A patent/KR100443891B1/ko not_active IP Right Cessation
- 1996-12-24 IL IL12510496A patent/IL125104A/en not_active IP Right Cessation
- 1996-12-24 EP EP03022894A patent/EP1394151A1/en not_active Withdrawn
- 1996-12-24 CN CNB011172541A patent/CN1159009C/zh not_active Expired - Fee Related
- 1996-12-24 KR KR10-2004-7004476A patent/KR100471351B1/ko not_active IP Right Cessation
- 1996-12-24 HU HU0000422A patent/HUP0000422A3/hu unknown
- 1996-12-24 CN CN96180052A patent/CN1092645C/zh not_active Expired - Fee Related
- 1996-12-24 DE DE69630465T patent/DE69630465T2/de not_active Expired - Lifetime
- 1996-12-24 AU AU11735/97A patent/AU716332B2/en not_active Ceased
- 1996-12-24 JP JP52417797A patent/JP3448869B2/ja not_active Expired - Fee Related
- 1996-12-24 US US09/091,993 patent/US6060496A/en not_active Expired - Lifetime
- 1996-12-24 NZ NZ324454A patent/NZ324454A/xx unknown
- 1996-12-24 CZ CZ19982012A patent/CZ294485B6/cs not_active IP Right Cessation
- 1996-12-24 RU RU98113956/14A patent/RU2173148C2/ru not_active IP Right Cessation
-
1998
- 1998-06-26 NO NO982988A patent/NO316494B1/no not_active IP Right Cessation
- 1998-06-26 IS IS4784A patent/IS4784A/is unknown
- 1998-06-29 MX MX9805317A patent/MX9805317A/es not_active IP Right Cessation
- 1998-07-15 BG BG102633A patent/BG63803B1/bg unknown
-
1999
- 1999-03-02 HK HK99100842A patent/HK1015777A1/xx not_active IP Right Cessation
-
2000
- 2000-02-04 US US09/498,481 patent/US6258834B1/en not_active Expired - Lifetime
-
2001
- 2001-05-08 US US09/850,000 patent/US20010036957A1/en not_active Abandoned
-
2002
- 2002-02-25 US US10/080,660 patent/US20020169194A1/en not_active Abandoned
-
2003
- 2003-01-30 US US10/354,136 patent/US20030130332A1/en not_active Abandoned
-
2004
- 2004-02-24 US US10/784,232 patent/US20040171663A1/en not_active Abandoned
-
2005
- 2005-06-15 US US11/152,376 patent/US20050239856A1/en not_active Abandoned
-
2006
- 2006-02-28 US US11/363,202 patent/US20060148875A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20002298B (en) | Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment | |
EA200000468A1 (ru) | Терапевтическая композиция для введения толтеродина с контролируемым высвобождением | |
ATE196081T1 (de) | L-dopa ester enthaltende zusammensetzung | |
CA2219115A1 (en) | N-benzyl-3-indoleacetic acids as cyclooxygenase-2-inhibitors and antiinflammatory drugs | |
RU93032613A (ru) | Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата | |
NO982988D0 (no) | Middel for profylakse og behandling av diabetiske komplikasjoner | |
MY129946A (en) | Compound with gastric acid inhibitory effect and process for its preparation. | |
HUP9802897A2 (hu) | Optikailag aktív piridil-4H-1,2,4-oxadiazin-származék, annak alkalmazása vaszkuláris betegségek kezelésére, valamint ilyen származékot hatóanyagként tartalmazó gyógyászati készítmény | |
AU695907B2 (en) | Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases | |
WO2002017917A8 (en) | Manzamines for treatment of drug resistant infection | |
FI964303A (fi) | Keuhkosydänvian hoitamiseen tarkoitettu aine | |
GB9216859D0 (en) | Medicaments | |
AU4519189A (en) | Medicaments for the treatment of toxoplasmosis | |
EP0822260A4 (en) | SUBSTANCE FA-70D, METHOD OF MANUFACTURE AND USES | |
RU94046312A (ru) | Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные | |
AU4519289A (en) | Medicament for the treatment of cryptosporidiosis | |
RU94045839A (ru) | Производные 3-(фенилалкиламиноалкилокси)-5-фенилпиразола, а также способ и промежуточные вещества для их получения, лекарственное средство, содержащее эти соединения | |
HUP0300043A2 (en) | Method and composition for the treatment of pain | |
TH20329A (th) | สิ่งป้องกันโรคและสิ่งหรือยาใช้รักษาโรคสำหรับบาดแผล และ/หรือการอักเสบซึ่งเกี่ยวกับตา | |
KR890000089A (ko) | 신장 질환 치료제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |